NEKTAR THERAPEUTICS

NKTR
Real-time Estimate Quote. Real-time Estimate  - 10/28 02:32:57 pm
15.865USD -3.73%

NEKTAR THERAPEUTICS : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

08/06/2020 | 05:24pm

Item 2.02 Results of Operations and Financial Condition.



On August 6, 2020, Nektar Therapeutics, a Delaware corporation ("Nektar"),
issued a press release (the "Press Release") announcing its financial results
for the quarter ended June 30, 2020. A copy of the Press Release is furnished
herewith as Exhibit 99.1.



On July 28, 2020, Nektar announced that it would hold a Webcast conference call
on August 6, 2020 to review its financial results for the quarter ended June 30,
2020
. This conference call is accessible through a link that is posted on the
home page and Investors section of the Nektar website: http://ir.nektar.com.



The information in this report, including the exhibit hereto, is being furnished
and shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as
amended. The information contained herein and in the accompanying exhibit shall
not be incorporated by reference into any filing with the Securities and
Exchange Commission
made by Nektar Therapeutics, whether made before or after
the date hereof, regardless of any general incorporation language in such
filing.



Item 9.01 Financial Statements and Exhibits.







Exhibit No. Description

99.1 Press release titled "Nektar Therapeutics Reports Second Quarter 2020
Financial Results" issued by Nektar Therapeutics on August 6, 2020.




1

© Edgar Online, source Glimpses

© Acquiremedia 2020
Copier lien
All news about NEKTAR THERAPEUTICS
10/02
08/12
08/07
08/06
08/06